Deep sleep and daytime urinary control more common in the treatment-responsive group
Read More »HealthDay.com
Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure
Defect-free quadruple medication therapy significantly improved at discharge, 30 days in patients with heart failure with reduced ejection fraction
Read More »Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
Combination of cochlear endolymphatic hydrops and vestibular endolymphatic hydrops achieves 100 percent diagnostic accuracy
Read More »Trader Joe’s Recalls Garlic Cheese Curds Due to Listeria Risk
By I. Edwards HealthDay ReporterMONDAY, June 23, 2025 (HealthDay News) — A cheese sold at Trader Joe’s has been recalled due to possible listeria contamination.The product is Face Rock Creamery’s Vampire Slayer Garlic Cheese Curds. It was sold at Trader Joe’s stores across Northern California and Northern Nevada, the company …
Read More »FDA Recalls Chocolate Candies Over Milk Allergy Risk
By I. Edwards HealthDay ReporterMONDAY, June 23, 2025 (HealthDay News) — Chocolate candy sold across the U.S. is being recalled because it may contain milk that isn’t listed on the label, the U.S. Food and Drug Administration (FDA) said.The agency announced the recall of multiple batches of semi-sweet chocolate nonpareils …
Read More »FDA Approves Once-Monthly Andembry for Hereditary Angioedema
The monoclonal antibody is a self-administered injection for prophylactic use to prevent attacks
Read More »Dietary Patterns Influence Development of Overactive Bladder
Antioxidant-balanced, diversified low-alcohol, and high-fiber low-sugar dietary patterns linked to reduced risk for OAB
Read More »Likelihood of Psych Disorders Lower With Weight-Loss Surgery Versus GLP-1 RAs
Lower risks for anxiety disorders, substance use disorders, cognitive deficits seen for those undergoing metabolic and bariatric surgery
Read More »Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years
Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics
Read More »Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.